Last updated: 2026-09-12 17:16:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Artivion, Inc. (AORT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $25,07, with a market capitalization of $1,20B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $19,16 to $48,25. This page covers its latest market performance, valuation, price trends and company information.
$1,20B | |
$24,96 | |
$48,25 | |
$9,64 | |
$24,65 | |
415,01K | |
716,29K | |
-- | |
$48,25 | |
$19,16 | |
-- | |
-- |
Artivion, Inc. (AORT) last closed at $24,65 as of 2026-09-11 23:31:00, unchanged from the previous close of $24,65.
During the latest regular trading session, AORT traded between $9,64 and $48,25, with a volume of 415,01K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Artivion, Inc. (AORT) moved from $26,34 to $25,07, representing a decline of 4,81% ($1,27).
The stock traded between $24,40 and $27,92 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 546,03 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 20,3%
AORT is currently trading at $25,07, placing it 20,3% of the way from its 52-week low of $19,16 to its 52-week high of $48,25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 1800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Artivion, Inc. (AORT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.